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Abstract: The aim of this study was to compare the symptomatology, palliative care outcomes,
therapeutic procedures, diagnostic tests, and pharmacological treatments for people with dementia
(PWD) and without dementia (PW/OD) admitted to Spanish nursing homes. Design: This was a
cross-sectional study which is part of a long-term prospective follow-up of elderly people performed
in nursing homes to measure end-of-life care processes. Participants: 107 nursing home patients
with advanced or terminal chronic diseases were selected according to the criteria of the Palliative
Care Spanish Society. Setting: Two trained nurses from each nursing home were responsible
for participant selection and data collection. They must have treated the residents and had a
minimum seniority of 6 months in the nursing home. Measurements: Sociodemographic data;
Edmonton Symptom Assessment Scale; Palliative Care Outcome Scale; and prevalence of diagnostic
tests, pharmacological treatments, and therapeutic procedures were evaluated. Results: Pain,
fatigue, and nausea were found to be significantly higher in the nondementia group and insomnia,
poor appetite, and drowsiness were significantly higher in the dementia group. Patient anxiety,
support, feeling that life was worth living, self-worth, and practical matters management were
higher in the nondementia group. Regarding drugs, use of corticoids was higher in the nondementia
group, while use of anxiolytics was higher in the dementia group. Diagnostic procedures such as
urine analysis and X-ray were higher in the dementia group. Conclusions: Differences in symptom
perception, diagnostic tests, and pharmacological procedures were found between patients with and
without dementia. Specific diagnostic tools need to be developed for patients with dementia.
Keywords: validation studies; nursing; nursing students; palliative care; self-efficacy
1. Introduction
Dementia is one of the main causes of disability and death in the elderly, affecting 35.6 million
people worldwide and steadily increasing [1]. Dementia currently affects around 10 million people in
the European Region, and its prevalence is expected to double by 2030. There is no cure for dementia,
and its development eventually leads to a loss of cognitive and physical functions.
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The probability of institutionalization increases significantly with occurrence of dementia
(odds ratio (OR) = 154.1) [2]. According to a recent review, poorer cognition, lack of community
resources, and uncontrolled behavioral and psychological symptoms are factors that have been linked
to institutionalization of older adults with dementia [3].
Because of that, there is a high prevalence of dementia in nursing homes among European
countries. A German study published in 2014 showed that the prevalence of dementia was 51.8% in
nursing home residents versus 2.7% in community-dwelling elderly [4]. Dementia prevalence was
even higher (77.0%) in a study conducted in East London [5].
In Spain, the functions attributed to hospices are assumed by other long-stay centers. In the case
of elderly patients, these functions are carried out mostly by nursing homes. Of all Spanish nursing
homes, 71.53% were private in 2019, for a total of 3844 private nursing homes. Private centers generally
offer a number of places arranged with the Public System [6]. Depending on the number of beds,
case complexity, and the legislation of each State, services are offered. In Andalusia (southern Spain),
for example, only nursing homes with over 60 beds are required to offer 24 h nursing services and their
own medical care [7].
In a three-year prospective study in northern Spain on a cohort of patients with palliative needs,
it was observed that almost a quarter of people with palliative needs live in nursing homes [8].
This population is mainly female and elderly, and the prevalent disease is dementia.
Nevertheless, research has demonstrated that in nursing homes, there is a high prevalence of
poorly controlled symptoms, such as urinary and fecal incontinence, psychological and behavioral
symptoms, pain, nausea, infections, restlessness, dyspnea, edema, and delirium [9–12].
A palliative care approach is needed for older people with dementia (PWD) institutionalized
in nursing homes. High-quality palliative care in nursing homes requires structured evaluation and
treatment of physical, psychosocial, emotional, and spiritual symptoms, as well as recognition of and
satisfaction with the information needs of patients with dementia and their relatives.
One of the pillars of the palliative approach is to reduce burdensome interventions that might not
have value at end of life and to focus on optimizing quality of life. Despite this, aggressive therapies,
prescription of futile drugs, and burdensome interventions are still commonplace in older nursing
home residents with advanced dementia [13,14]. Health professionals often face dilemmas regarding
whether the time has come to not start or to withdraw treatments and interventions because they do
not add quality of life [15]. A study conducted in the Netherlands [16] recommended that professionals
should respond early to palliative care needs and encourage discussions with patients with dementia
and their families about how to deal with therapeutic procedures and drug therapy at the end of life.
Nevertheless, differences in palliative care outcomes, symptoms, and interventions between
residents with or without dementia who potentially require palliative care have not yet been examined.
Furthermore, no studies have been found that quantitatively evaluate these outcomes in residents with
or without dementia in the Spanish context.
We hypothesized that patients without dementia (PW/OD) would have different symptoms
and palliative outcomes, consume different drugs, and undergo different diagnostic and therapeutic
procedures than patients with dementia.
Related to symptoms, our hypothesis was that patients without dementia would experience more
frequently and more intensely symptoms requiring self-identification as pain, fatigue, anorexia, nausea,
depression, or anxiety than patients with dementia, while other symptoms would be experienced
equally by both groups of patients.
Concerning palliative outcomes, the starting hypothesis was that patients with dementia would
present worse outcomes in those aspects related to communication and self-esteem, as well as
family anxiety, than those patients without dementia. Patients with dementia would consume more
psychopharmaceuticals (anxiolytics, hypnotics, and barbiturates) and fewer analgesics, antiemetics,
and antidepressants than patients without dementia due to the limited assessment of pain and other
patient-referred symptoms in patients with cognitive impairment. On the other hand, we hypothesized
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that the use of antibiotics would be higher in patients with dementia. The use of diagnostic procedures
would be higher in patients with dementia due to the difficulty in diagnosing concurrent pathologies.
On the contrary, the use of therapeutic procedures would be lower in patients with dementia than in
the rest of the patients.
The aims of this study were (i) to describe symptoms perceived by professionals, palliative care
outcomes, pharmacological treatments, diagnostic tests, and therapeutic procedure interventions and
of older adults identified as palliative care patients in Spanish nursing homes and (ii) to compare
existing differences between palliative care patients with dementia and those without dementia.
2. Materials and Methods
2.1. Design
A cross-sectional study was carried out in 6 nursing homes in the Metropolitan Health District
of Granada.
2.2. Setting and Participants and Data Collection Procedure
Nursing homes were selected based on their institutional characteristics. All had more than 60
beds and were privately funded. The selection of the nursing homes was performed as a convenience
selection based on the presence of a multidisciplinary team, professionals interested in the possible
involvement in the study, and the offer of both public and private beds. The research team explained
the aims of the study to nursing homes managers. In each center, one or two nurses with close
knowledge of the residents and who had been working at the nursing home for at least 6 months were
responsible for data collection. All the nurses who participated gave their informed consent. In order
to control bias and to produce reliable data for the research, these professionals received a training
course designed to explain the study in order to ensure uniformity of data collection. The research
team was in contact with them by phone if new questions or scenarios were presented and they visited
the centers regularly, at least once a month.
Each nursing home professional selected patients with chronic diseases that met the following
criteria according to the Spanish Society of Palliative Care (“Sociedad Española de Cuidados
Paliativos”—SECPAL):
- Advanced, progressive, and incurable disease
- Lack of reasonable possibilities of response to a specific treatment
- Presence of numerous problems or intense, multiple, multifactorial, and changing symptoms
- Great emotional impact on patient, family, and staff
- Life expectancy limited to 6 months.
Twenty patients meeting the above inclusion criteria were selected from each center for
randomized follow-up. They were observed and the data of interest were recorded without
interfering with the natural course of events. Data were collected between June 2016 and January
2017. All participants, patients, and caregivers were fully informed and signed the informed consent
agreement. Informed consent was given by the patient if he or she did not have dementia and by the
patient’s representative in the case of patients with dementia. Thirteen patients dropped out of the
study: 3 of them moved on to another nursing home and 10 did not provide informed consent by
either the patient or the representative. Among these 10, 6 had dementia and 4 did not.
2.3. Instruments
A structured questionnaire was used to collect sociodemographic (age, gender, years in the center)
and clinical (medical diagnosis, Charlson Comorbidity Index) data from patient records.
For the systematic symptom assessment, we used the Edmonton Symptom Assessment System
(ESAS) [17], the Spanish version of which has been validated in palliative care settings and is easy
Int. J. Environ. Res. Public Health 2020, 17, 1465 4 of 12
to complete and to interpret. The ESAS has been validated for both patient and caregiver reports in
different settings, including those with older people with multiple morbidities [18]. ESAS was used
regularly in all the nursing homes that participated in the study for symptom assessment.
Palliative care outcomes were measured with the Palliative Outcome Scale (POS). The POS is a
10-item multidimensional scale that covers physical, psychological, emotional, and spiritual domains
of life. It is a suitable instrument for evaluating palliative care needs coverage and symptoms of people
with or without dementia [19]. The Spanish version of the POS [20] was found to be internally consistent
(patient version α = 0.64, staff version α = 0.62). The Spanish POS correlated with emotional function
and quality of life scales. For dementia patients, ESAS and POS were assessed by trained professionals.
An ad hoc questionnaire was used to identify whether certain interventions had been performed
(at least once) in the past month. We evaluated interventions such as common drug prescriptions at
end of life (nonopioid analgesics, opioid analgesics, antibiotics, bronchodilators, corticoids, antiemetics,
antihistamines, antidepressants, anxiolytics, and hypnotics/barbiturates), diagnostic tests (urine
analysis, spirometry, electrocardiograms, X-rays, endoscopy, blood cultures, ultrasound, gammagraphs,
electrocardiograms, blood analysis, and gasometry), and therapeutic procedures (urinary catheter,
nasogastric catheter, peripheral catheter, enteral nutrition, aerosol sprays, and oxygen therapy) which
were used in the past month.
2.4. Data Analysis
A descriptive analysis was carried out to describe the main characteristics of the study population.
Numerical variables were described by medians and interquartile ranges (P25–P75) and categorical
variables by absolute frequencies and percentages.
Quantitative variables were assessed for normality using the Kolmogorov–Smirnov test and
all were found to deviate significantly from the normal distribution (p < 0.01). Because of this,
nonparametric inferential tests were used.
A chi-squared test was used to assess independence between categories and the Mann–Whitney
U test was used to assess differences between two independent samples. Statistical analysis was
performed using IBM SPSS v.25© (IBM Corporation, Armonk, New York, United States); p-values of
less than 0.05 were considered significant. OR and 95% confidence interval were calculated for each
variable in which statistically significant differences were found between the two groups.
2.5. Ethical Considerations
All participants (PW/OD) or representatives (PWD) gave their informed consent. The study
received the approval of the Granada Research Ethics Committee (PI-0619-2011). In compliance with
Spanish law (Article 16, Law 41/2002), patients’ data were anonymized.
3. Results
3.1. Participants
Overall, 120 patients were selected, but 13 of them were lost for various reasons, such as transfers
to other centers. A total 107 nursing home residents were assessed. Residents’ mean age was 84 (81–89)
years, and 63.6% of the residents were women. The median length of the nursing home stay was 2.0
years. Chronic Obstructive Pulmonary Disease (COPD) had a significantly higher prevalence among
PW/OD than in the PWD group (p = 0.05). Other sociodemographic and clinical data of the sample are
shown in Table 1.
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Table 1. Sociodemographic and clinical characteristics of the patients.




(n = 56) p
Age, md (P25–P75) 84 (81–89) 85 (82–92) 83.5 (77–89) 0.142a
Female, n(%) 68 (63.6) 33 (64.7) 35 (62.5) 0.972a
Years in the center, md (P25–P75) 2 (1–4) 2 (1.7–5) 2 (1–4) 0.500b
CCI, md (P25–P75) 3.5 (2–6) 4 (3–6) 3 (2–6) 0.228a
Coexisting conditions
Myocardial infarction, n(%) 6 (5.6) 3 (6.1) 3 (5.4) 0.866b
Heart failure, n(%) 28 (26.2) 11 (22.4) 17 (30.4) 0.488b
Peripheral vascular disease, n(%) 10 (9.3) 6 (12.2) 4 (7.1) 0.579b
Thromboembolic disease, n(%) 7 (6.5) 3 (6.1) 4 (7.1) 1.000b
Vascular brain ictus/damage, n(%) 45 (42.1) 25 (51.0) 20 (35.7) 0.167b
Hemiplegia, n(%) 14 (13.1) 4 (8.2) 10 (17.9) 0.242b
Arterial hypertension, n(%) 63 (58.9) 28 (57.1) 35 (62.5) 0.719b
COPD, n(%) 25 (23.4) 5 (10.2) 20 (35.7) 0.005b
Arrhythmia, n(%) 21 (19.6) 12 (24.5) 9 (16.1) 0.406b
Renal disease, n(%) 19 (17.8) 8 (16.3) 11 (19.6) 0.852b
Diabetes, n(%) 34 (31.8) 17 (36.2) 18 (32.7) 0.879b
Malignant tumor, n(%) 17 (15.9) 6 (12.2) 11 (19.6) 0.447b
Solid tumor with metastasis, n(%) 10 (9.3) 2 (4.1) 8 (14.3) 0.149b
PWD, patients with dementia; PW/OD, patients without dementia; CCI, Charlson Comorbidity Index; COPD, Chronic
Obstructive Pulmonary Disease; a: Mann–Whitney; b: chi-squared; md, median; (P25–P75) interquartile range.
3.2. Perception of Symptom Intensity
In terms of end-of-life-related symptoms evaluated through the ESAS (Table 2), the most intense
symptom for the group with dementia was dyspnea (x̃ = 7; range = [4–9]), followed by drowsiness
(x̃ = 6; range = [4–8]), while for the group without dementia, the most intense symptoms were fatigue
(x̃ = 7; range = [5–8]) and depression (x̃ = 7; range = [3–8]). In both groups, the most prevalent symptom
was pain. Statistically significant differences were observed in pain (p = 0.002), fatigue (p = 0.025),
nausea (p = 0.035), poor appetite (p = 0.004), and insomnia (p = 0.042), with higher scores in the group
without dementia. Drowsiness (p = 0.002) was rated higher in the dementia group. No differences in
total scale score were observed when comparing groups (Table 2).
Table 2. Comparison of intensity of perceived symptoms using the Edmonton Symptom Assessment
System (ESAS) in patients of Nursing Homes with or without dementia.
Symptoms and Concerns % (Total) PWD a PW/OD a p b
1. Pain 87.9 (94) 3.5 (2–6) 6 (4–7) 0.002
2. Fatigue 82.2 (88) 5 (4–7) 7 (5–8) 0.025
3. Nausea 33.6 (36) 3 (2–4) 4.5 (3–6) 0.035
4. Depression 61.7 (66) 4 (3–7) 7 (3–8) 0.115
5. Anxiety 62.6 (67) 5 (4–6) 5.5 (4–8) 0.184
6. Drowsiness 86.0 (92) 6 (4–8) 4 (2–6) 0.002
7. Poor appetite 68.2 (73) 4 (2–6) 6 (5–8) 0.004
8. Not feeling well 74.8 (80) 6 (4–7) 6 (5–7) 0.197
9. Dyspnea 54.2 (58) 7 (4–9) 6 (2–8) 0.194
10. Insomnia 64.5 (69) 3 (2–7) 6 (4–8) 0.042
TOTAL 92.5 (99) 3 (2–5) 4 (2–6) 0.613
a median score and interquartile range; b Mann–Whitney.
3.3. Palliative Care Outcomes
Regarding palliative care outcomes, the mean score of the global POS of the group with dementia
ranked between one and two, while those of the group without dementia ranked between two and
three. More intense anxiety (p = 0.05) and depression (p = 0.05) were observed in the nondementia
group compared with the dementia group. As shown in Table 3, the group with dementia spent
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more time waiting or repeating tests than the group without dementia (p = 0.49). However, the group
without dementia showed higher scores for sharing their feelings with their family (p = 0.001) and more
practical matters (p = 0.002) than patients with dementia. As for the Eastern Cooperative Oncology
Group (ECOG), patients in the dementia group were more dependent than those in the nondementia
group (p = 0.001). The total score was lower in the group of patients with dementia.
Table 3. Perception of palliative care outcomes reported by the Palliative Outcome Scale (POS) in
patients of NH with dementia (PWD) and without dementia (PW/OD).
Palliative Care Outcomes % (Total) PWD PW/OD p a
1. Has the patient been affected by pain? (from 0 = “Not at all” to
4 = “Overwhelmingly”) 87.9 (94) 1 (1–2) 1 (1–2) 0.069
2. Does the patient’s other symptoms (e.g., nausea, coughing, or
constipation) seem to be affecting how well s/he feels? (from 0 = “Not at
all” to 4 = “Overwhelmingly”)
74.8 (80) 2 (1–2) 2 (1–2) 0.775
3. Has s/he been feeling anxious or worried about her/his illness or
treatment? (from 0 = “Not at all” to 4 = “The patient does not seem to think
of anything else”)
59.8 (64) 2 (1–2) 2 (2–3) 0.050
4. Have any of their family or friends been anxious or worried about the
patient? (from 0 = “Not at all” to 4 = “Yes, they always seem preoccupied
with worry”)
89.7 (96) 3 (2–3) 2 (2–3) 0.111
5. How much information has been given to the patient and his/her family
or friends? (from 0 = “Full information or as much as wanted” to
4 = “None at all”)
83.2 (89) 3 (3–4) 4 (3–4) 0.232
6. Has the patient been able to share how s/he is feeling with family or
friends? (0 = “Yes, as much as s/he wanted to” to 4 = “No, not at all with
anyone”)
60.7 (65) 1.5 (1–3) 3 (2–4) 0.001
7. Do you think the patient has felt good about his/herself? (from 0 = “Yes,
all the time” to 4 = “No, not at all”) 52.3 (56) 2 (1–2) 2 (1–4) 0.050
8. Do you think s/he felt life was worth living? (from 0 = “Yes, all the time”
to 4 = “No, not at all”) 60.7 (65) 2 (1–2) 2 (1–3) 0.065
9. How much time do you feel has been wasted on appointments relating to
the healthcare of this patient (e.g., waiting around for transport or repeating
tests)? (from 0 = “None at all” to 4 = “More than half a day wasted”)
85.0 (91) 2 (2–2) 2 (1–2) 0.049
10. Have any practical matters resulting from his/her illness, either
financial or personal, been addressed? (from 0 = “Practical problems have
been addressed and his/her affairs are as up to date as s/he would wish” to
4 = “Practical problems exist which were not addressed”)
45.8 (49) 2 (2–3) 3 (2–3) 0.002
11. Eastern Cooperative Oncology Group (ECOG) 100.0 (107) 3 (3–4) 2 (1–3) 0.001
Total 96.3 (103) 18 (15–21) 20 (18–24) 0.022
a Mann–Whitney.
3.4. Pharmacological Treatments, Diagnostic Tests, and Therapeutic Procedures
The most commonly used drugs for patients with dementia were hypnotics and barbiturates
(62.7%), followed by analgesics (60%) and antidepressants (33%). For the group without
dementia, 60.7% received nonopioid analgesics, followed by anxiolytics and bronchodilators (32.1%).
Statistically significant differences were observed for corticoids (p = 0.035) and anxiolytics (p = 0.005).
The percentage of patients with corticosteroids was higher in the nondementia group, while the
percentage of patients with anxiolytics was higher in the dementia group.
Patients with dementia showed a higher probability of taking anxiolytics than those without
dementia (OR = 3.521). Patients with dementia showed a lower probability of taking corticoids than
those without dementia (OR = 0.306), as shown in Table 4.
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Table 4. Comparison of pharmacological treatments in patients of NH with dementia (PWD) and
without dementia (PW/OD).
Pharmacological Treatments PWD(n = 51)
PW/OD
(n = 56) p
b OR (95% CI)
Nonopioid analgesics, (%) 60.0 60.7 1.000
Opioid analgesics, (%) 14.9 16.4 1.000
Antibiotics, (%) 23.5 21.4 0.978
Bronchodilators, (%) 23.5 32.1 0.438
Corticoids, (%) 11.8 30.4 0.035 0.306 (0.109; 0.853)
Antiemetics, (%) 9.8 8.9 1.000
Antihistamines, (%) 9.8 8.9 1.000
Antidepressants, (%) 33.3 32.1 1.000
Anxiolytics, (%) 49.0 21.4 .005 3.521 (1.520; 8.198)
Hypnotics/barbiturates, (%) 62.7 32.1 .839
b chi-squared; OR (95% CI), odds ratio (95% confidence interval of the odds ratio).
Regarding the diagnostic tests, almost half of the patients in the dementia group (45.1%) had a
urine test and 38.3% had a blood test. On the other hand, in the group without dementia, 32.7% had a
blood analysis and 19.6% had a urine analysis. It is notable that in the case of X-rays, in the group
with dementia, 17.5% were performed, while in the group without dementia, no case was reported.
Greater use of urine analysis (p = 0.009) and X-rays (p = 0.009) was observed in patients with dementia
compared with patients without dementia (Table 5).
Patients with dementia showed 3.356 (1.422; 7.937) and 25.393 (1.430; 446.200) times the probability
of having a urinalysis and X-ray performed than those without dementia, respectively.
Table 5. Comparison of diagnostic tests in patients of NH with dementia (PWD) and without dementia
(PW/OD).
Diagnostic Tests PWD(n = 51)
PW/OD
(n = 56) p
b OR (95% CI)
Urine analysis, (%) 45.1 19.6 0.009 3.356 (1.422; 7.937)
Spirometry, (%) 2.0 3.6 1.000
Electrocardiograms, (%) 3.0 3.6 1.000
X-rays, (%) 17.6 0.0 0.003 25.393 (1.430; 446.200)
Endoscopy, (%) 3.9 0.0 0.225
Blood cultures, (%) 5.9 0.0 0.105
Ultrasound, (%) 5.9 3.6 0.668
Gammagraphs, (%) 2.0 0.0 0.477
Electrocardiograms, (%) 19.1 14.5 0.722
Blood analysis, (%) 38.3 32.7 0.705
Gasometry, (%) 9.8 3.6 0.254
b chi-squared (Fisher’s exact test); OR (95% CI), odds ratio (95% confidence interval of the odds ratio).
For the group with dementia, 25.5% had an IV peripheral catheter and 23.7% carried a urinary
catheter. Only 19.6% and 15.7% had oxygen therapy and aerosol sprays, respectively. For the group
without dementia, the most frequent interventions were oxygen therapy (39.3%) and aerosol sprays
(32.1%). The use of oxygen therapy was significantly less frequent among patients with dementia
(OR = 0.378) (Table 6).
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Table 6. Comparison of therapeutic procedures in patients of NH with dementia (PWD) and without
dementia (PW/OD).
Therapeutic Procedures PWD(n = 51)
PW/OD
(n = 56) p
b OR (95% CI)
Urinary catheter, (%) 23.7 13.2 0.176
Nasogastric catheter, (%) 19.6 10.7 0.309
IV peripheral catheter, (%) 25.5 26.8 1.000
Enteral nutrition, (%) 15.7 7.1 0.275
Aerosol sprays, (%) 15.7 32.1 0.079
Oxygen therapy, (%) 19.6 39.3 0.045 0.378 (0.329; 0.994)
b chi-squared; OR (95% CI), odds ratio (95% confidence interval of the odds ratio).
4. Discussion
Intensity of perceived symptoms, diagnostic and therapeutic procedures, and quality of palliative
care were found to differ between residents with or without dementia in Spanish nursing homes.
Our results showed that pain, fatigue, and nausea were significantly higher in the nondementia
group. On the other hand, insomnia, poor appetite, and drowsiness were significantly higher in
the dementia group. Concerning drugs, use of corticoids was higher in the nondementia group,
while use of anxiolytics was higher in the dementia group. Diagnostic procedures such as urine
analysis and X-ray were higher in the dementia group. Patient anxiety, lack of perceived support,
lack of self-worth, and lack of practical matters management were higher in the nondementia group.
Below, the implications for practice and research are discussed.
Although no differences were observed between groups in terms of total ESAS scale score,
significant differences were observed between different symptoms. Pain is one of the most studied
symptoms in residents with dementia institutionalized in nursing homes [11,12,21–23]. As our results
highlighted, this symptom is usually one of the most prevalent in advanced stages and at the end
of life [11]. Despite this, there is great difficulty in assessing pain in dementia patients because
nonverbal signs of pain can be misinterpreted as neuropsychiatric or behavioral symptoms [11,21,23].
Smedbäck et al. [11] pointed out the need to develop specific scales for patients with dementia to help
assess this and other symptoms.
According to our hypothesis and previous studies [12,24,25], other self-reported symptoms
such fatigue, nausea, poor appetite, and insomnia were rated higher in nondementia patients. As it
happens with pain, this may be linked to a lack of assessment tools [11,26] rather than a real low
prevalence/intensity of these symptoms in dementia patients [24].
Regarding palliative care outcomes, contrary to our initial hypothesis, the mean score of the POS
was higher in nondementia patients, who also showed more anxiety, a lack of family support, and felt
worst about themselves than dementia patients. Again, this could be linked to the absence of specific
validated tools in the Spanish context to report anxiety and depression in dementia patients. As with
the ESAS, POS data of dementia patients were reported by professionals. Nevertheless, professionals
of nursing homes are not well trained in recognizing and treating emotional problems in dementia
patients [12,27].
Although family anxiety was found to be higher in dementia patients, this difference was
not statistically significant. It could be expected that families of dementia patients in nursing
homes report higher levels of anxiety [24,28]. However, the anxiety of family members is high in
dementia and nondementia patients, especially when faced with situations related to end-of-life
decision-making [29,30].
According to our results, having dementia does not seem to be an impediment to receiving
information, compared to those without dementia. It is necessary to highlight that the POS includes all
the information that has been given both to the patient or the family. Communication is a challenge for
dementia patients’ relatives, but it is not only for them. In fact, Hermans et al. [31] showed in their results
that patients with dementia received less information and received less support from their families
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than the patients in the group without dementia. In our study, there were no statistically significant
differences for given information between groups. Differences found between Hermans et al. [31] and
our results may be due to different cultural patterns in dealing with institutionalized patients [32].
On the other hand, professionals and families spend more time on appointments related to
healthcare. This may be due to greater difficulty in diagnosing pain or other symptoms and their
possible causes [21].
In terms of the drugs used, contrary to the initial hypothesis, although more pain was reported in
patients without dementia than in patients with dementia, no differences were observed in analgesic
consumption. This absence of differences may indicate that pain is underevaluated and undertreated
in nursing homes [23,33,34]. However, it is difficult to know if patients are receiving enough analgesia,
even in nondementia patients [23]. In a study carried out in Polish nursing homes, only 30% of
residents with moderate or severe cognitive impairment were treated with analgesics. Most of them
received medication from the first step of the analgesic scale, and only a few received opioids even if
they experienced moderate pain [23].
Physicians have shown a preference to start with a weak analgesic, such as a Nonsteroidal
Anti-Inflammatory Drug (NSAID), and gradually move upwards, rather than begin with powerful
analgesics such as opioids [21]. In our study, although no differences were observed between groups,
the percentage of opioid intake was lower than in other studies conducted in nursing homes with
similar samples. Hendriks et al. [9] found that pain was recognized in 73% of patients, but in this study,
patients were evaluated only in the last week of life, where pain is more prevalent and intense.
Regarding antibiotic consumption, a study carried out by van den Noortgate et al. [33] in Belgian
nursing homes observed the last 48 h of life in these institutions. In this study, 63.6% of the patients
consumed antibiotics.
In our results, contrary to the initial hypothesis, no statistically significant difference was found in
antibiotic consumption between groups, as opposed to what was observed by Hendriks et al. [16] in
their study, which showed greater antibiotic intake in patients with dementia.
According to our hypothesis, no differences were found in reported anxiety between dementia
and nondementia patients, and a greater administration of anxiolytics and hypnotics/barbiturates was
observed in the group with dementia. Agitation and restlessness can have several causes, such as pain
or emotional distress [21]. Diagnosing the cause in dementia patients is very complicated because most
of the time, these patients cannot verbally report these symptoms and this may lead to undertreatment
or mistreatment. Other psychotropic drugs such as antipsychotics or barbiturates should be analyzed
in further studies.
Due to the difficulties in diagnosing concurrent diseases or complications in dementia patients,
according to our hypothesis, higher percentages of diagnostic procedures were observed in these
patients for many of the evaluated tests, although statistically significant differences were only found
in urine analysis and X-ray tests. The difficulty of diagnosing urinary tract infections has been
previously reported in patients with advanced dementia in nursing homes [35]. Similarly, the high
prevalence of microfractures in older adults with dementia (men and women, 80 years or more) has
been reported in other study [36]. Hommel et al. [36] additionally remarked that these fractures are
often underdiagnosed and may be considered as a cause of pain-related signs in dementia patients.
Regarding therapeutic procedures, contrary to the initial hypothesis, there were no differences
between groups. This is consistent with the literature, where patients with dementia are not usually
subjected to onerous interventions [16]. Nevertheless, we found statistically significant differences
between groups for aerosol sprays and oxygen therapy. This may be due to difficulty in evaluation as
well as other symptoms such as pain, which is reflected in undertreatment [33,34].
Some limitation should be pointed out. For this study, palliative patients were identified according
to current Spanish Society of Palliative Care (“Sociedad Española de Cuidados Paliativos”—SECPAL)
criteria, but since the data collection procedure finished, specific tools such as the NECPAL-CCOMS-ICO
© tool [37] have been developed and improved to assess palliative needs of advanced chronic patients,
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like those selected for this study, in the Spanish context. Nevertheless, the SECPAL criteria were the
most widely used criteria for the Spanish population at the beginning of data collection. On the other
hand, as it has been pointed out in the discussion section, although the ESAS and POS have been used
for dementia patients before [19], it is necessary to develop and adapt to the Spanish context specific
tools to evaluate symptoms and palliative care outcomes in these patients. It should be remembered that
data on symptom intensity and prevalence as well as POS items have been reported by professionals.
This carries a potential bias, as professionals may over- or underestimate certain aspects.
Finally, sample size may be a limitation for analysis in order to find other statistically significant
differences between the two populations. Regardless, our study showed numerous differences with
a high level of significance in spite of the sample size. However, the results of this study should
be interpreted with caution, as they refer to a specific geographical context. Comparisons between
different countries should be made in the future so that the differences found can be generalized.
5. Conclusions
Pain, fatigue, and nausea were found to be significantly higher in patients without dementia.
In contrast, insomnia, poor appetite, and drowsiness were significantly higher in the dementia patients.
Regarding drugs, use of corticoids was higher in the nondementia group, while use of anxiolytics was
higher in the dementia group. Diagnostic procedures such as urine analysis and X-ray were higher in the
dementia group. Patient anxiety, lack of perceived support, and lack of practical matters management
were higher in nondementia patients, while more time was wasted on healthcare appointments in the
dementia group. Specific tools are needed in order to evaluate symptoms and palliative care outcomes
in dementia patients.
This is one of the first studies to evaluate and compare symptoms, pharmacological treatments,
diagnostic and treatment procedures, and palliative outcomes between dementia and nondementia
patients in nursing homes. This study provides valuable data about which symptoms are more
prevalent and intense in dementia and nondementia patients, which are the most performed procedures,
and which are the unmet palliative care needs.
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